Repke J. Snijder

5.4k total citations
87 papers, 2.5k citations indexed

About

Repke J. Snijder is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Repke J. Snijder has authored 87 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 50 papers in Genetics and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Repke J. Snijder's work include Vascular Anomalies and Treatments (50 papers), Pulmonary Hypertension Research and Treatments (42 papers) and Tracheal and airway disorders (37 papers). Repke J. Snijder is often cited by papers focused on Vascular Anomalies and Treatments (50 papers), Pulmonary Hypertension Research and Treatments (42 papers) and Tracheal and airway disorders (37 papers). Repke J. Snijder collaborates with scholars based in Netherlands, United States and Canada. Repke J. Snijder's co-authors include Johannes J. Mager, Martijn C. Post, Jules M.M. van den Bosch, Cornelis J.J. Westermann, C. J. J. Westermann, H. W. M. Plokker, Sebastiaan Velthuis, Christine L. Mummery, Marco W.F. van Gent and F. J. M. Disch and has published in prestigious journals such as Circulation, Nature Medicine and Blood.

In The Last Decade

Repke J. Snijder

87 papers receiving 2.5k citations

Peers

Repke J. Snijder

PRM

GENET

CCM

SURGE

MARKE

P. Duffau France

Philip Seo United States

Élisabeth Diot France

Roberto Dore Italy

L Stockx Belgium

R.J. Berckmans Netherlands

Nancy B. Allen United States

Shunsuke Endo Japan

Katsuhiro Takano Japan

Shruti Chaturvedi United States

P. Duffau France

Repke J. Snijder

225 ×0.1

PRM

181 ×0.2

GENET

64 ×0.1

CCM

146 ×0.3

SURGE

22 ×0.1

MARKE

Citations per year, relative to Repke J. Snijder Repke J. Snijder (= 1×) peers P. Duffau

Countries citing papers authored by Repke J. Snijder

Since Specialization

Citations

This map shows the geographic impact of Repke J. Snijder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Repke J. Snijder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Repke J. Snijder more than expected).

Fields of papers citing papers by Repke J. Snijder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Repke J. Snijder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Repke J. Snijder. The network helps show where Repke J. Snijder may publish in the future.

Co-authorship network of co-authors of Repke J. Snijder

This figure shows the co-authorship network connecting the top 25 collaborators of Repke J. Snijder. A scholar is included among the top collaborators of Repke J. Snijder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Repke J. Snijder. Repke J. Snijder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Humbert, Marc, Gérald Simonneau, David Pittrow, et al.. (2022). Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension. The Journal of Heart and Lung Transplantation. 41(6). 716–721. 34 indexed citations

Bakker, Annelies L.M., et al.. (2021). Clinical Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension. Heart Lung and Circulation. 30(10). 1502–1508. 8 indexed citations

Bakker, Annelies L.M., et al.. (2020). Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series.. PubMed Central. 37(1). 74–78. 12 indexed citations

Snijder, Repke J., et al.. (2019). Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. IJC Heart & Vasculature. 22. 163–168. 28 indexed citations

Snijder, Repke J., et al.. (2019). Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?. Lung. 197(6). 753–760. 6 indexed citations

Leiner, Tim, Gertjan T. Sieswerda, Arie P.J. van Dijk, et al.. (2018). RV adaptation to increased afterload in congenital heart disease and pulmonary hypertension. PLoS ONE. 13(10). e0205196–e0205196. 10 indexed citations

Sieswerda, Gertjan T., Pieter A. Doevendans, Erik H.J. Hulzebos, et al.. (2018). Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography. Journal of Cardiovascular Magnetic Resonance. 20(1). 5–5. 40 indexed citations

Snijder, Repke J., et al.. (2018). Systematic screening in hereditary hemorrhagic telangiectasia. Current Opinion in Pulmonary Medicine. 24(3). 260–268. 16 indexed citations

Velthuis, Sebastiaan, Anna E. Hosman, C. J. J. Westermann, et al.. (2018). Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia. Netherlands Heart Journal. 26(4). 203–209. 7 indexed citations

10.

Velthuis, Sebastiaan, Jan Albert Vos, Repke J. Snijder, et al.. (2017). SMAD4 gene mutation increases the risk of aortic dilation in patients with hereditary haemorrhagic telangiectasia. International Journal of Cardiology. 245. 114–118. 25 indexed citations

11.

Dendooven, Amélie, et al.. (2017). Pulmonary artery aneurysms and thrombi. Thorax. 72(12). 1167–1168. 1 indexed citations

12.

Snijder, Repke J., Maarten J. Suttorp, Jurriën M. ten Berg, & Martijn C. Post. (2017). Percutaneous closure of a patent foramen ovale after cryptogenic stroke. Netherlands Heart Journal. 26(1). 5–12. 4 indexed citations

13.

Gkatzis, Konstantinos, Sabrina Martín, Noël Lamandé, et al.. (2016). Interaction Between ALK1 Signaling and Connexin40 in the Development of Arteriovenous Malformations. Arteriosclerosis Thrombosis and Vascular Biology. 36(4). 707–717. 19 indexed citations

14.

Velthuis, Sebastiaan, Elisabetta Buscarini, Johannes J. Mager, et al.. (2014). Predicting the size of pulmonary arteriovenous malformations on chest computed tomography: a role for transthoracic contrast echocardiography. European Respiratory Journal. 44(1). 150–159. 40 indexed citations

15.

Bresser, Paul, Jeroen C. Vis, Rolf M.F. Berger, et al.. (2011). Predictors of long-term survival in pulmonary hypertension treated with bosentan. The Journal of Heart and Lung Transplantation. 1 indexed citations

16.

Gent, Marco W.F. van, Martijn C. Post, Repke J. Snijder, et al.. (2010). Real Prevalence of Pulmonary Right-to-Left Shunt According to Genotype in Patients With Hereditary Hemorrhagic Telangiectasia. CHEST Journal. 138(4). 833–839. 59 indexed citations

17.

Post, Martijn C., M Gent, H. W. M. Plokker, et al.. (2009). Pulmonary arteriovenous malformations associated with migraine with aura. European Respiratory Journal. 34(4). 882–887. 30 indexed citations

18.

Letteboer, Tom G.W., et al.. (2008). Genotype–phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia. American Journal of Medical Genetics Part A. 146A(21). 2733–2739. 47 indexed citations

19.

Gent, Marco W.F. van, Martijn C. Post, Repke J. Snijder, et al.. (2008). Grading of Pulmonary Right-to-Left Shunt With Transthoracic Contrast Echocardiography. CHEST Journal. 135(5). 1288–1292. 54 indexed citations

20.

Schutgens, Roger E. G., Repke J. Snijder, Fred J.L.M. Haas, et al.. (2004). Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism. Journal of Laboratory and Clinical Medicine. 144(2). 100–107. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact